Search Count: 34
 |
Hiv-1 Integrase Catalytic Core Domain (Ccd) F185H/Y99H/A128T Mutant Complexed With Ekc-110
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:2.07 Å Release Date: 2024-06-19 Classification: VIRAL PROTEIN Ligands: QD6 |
 |
Hiv-1 Integrase Catalytic Core Domain (Ccd) F185H/Y99H/A128T Mutant Complexed With Stp03-0404
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.93 Å Release Date: 2024-06-19 Classification: VIRAL PROTEIN Ligands: WBV |
 |
Hiv-1 Integrase Catalytic Core Domain And C-Terminal Domain In Complex With Allosteric Integrase Inhibitor Ekc-110
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:2.08 Å Release Date: 2024-06-19 Classification: VIRAL PROTEIN Ligands: QD6, MG |
 |
Hiv-1 Integrase Catalytic Core Domain (Ccd) F185H Mutant Complexed With Stp03-0404
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:2.26 Å Release Date: 2024-02-07 Classification: VIRAL PROTEIN Ligands: WBV |
 |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.84 Å Release Date: 2023-06-14 Classification: VIRAL PROTEIN Ligands: QD6 |
 |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:2.29 Å Release Date: 2022-11-02 Classification: VIRAL PROTEIN Ligands: IOD, CL |
 |
Disulfide Stabilized Hiv-1 Ca Hexamer In Complex With Capsid Inhibitor N-(1-(3-(4-Chloro-1-Methyl-3-(Methylsulfonamido)-1H-Indazol-7-Yl)-4-Oxo-3,4-Dihydropyrido[2,3-D]Pyrimidin-2-Yl)-2-(3,5-Difluorophenyl)Ethyl)-2-(3-(Trifluoromethyl)-4,5,6,7-Tetrahydro-1H-Indazol-1-Yl)Acetamide
Organism: Human immunodeficiency virus type 1 group m subtype b (isolate bh10)
Method: X-RAY DIFFRACTION Resolution:2.39 Å Release Date: 2022-10-05 Classification: VIRAL PROTEIN Ligands: 9VI, IOD, CL |
 |
Disulfide Stabilized Hiv-1 Ca Hexamer In Complex With Capsid Inhibitor N-(1-(3-(4-Chloro-1-Methyl-3-(Methylsulfonamido)-1H-Indazol-7-Yl)-4-Oxo-3,4-Dihydropyrido[2,3-D]Pyrimidin-2-Yl)-2-(3,5-Difluorophenyl)Ethyl)-2-(3-(Difluoromethyl)-5,6-Dihydrocyclopenta[C]Pyrazol-1(4H)-Yl)Acetamide
Organism: Human immunodeficiency virus type 1 group m subtype b (isolate bh10)
Method: X-RAY DIFFRACTION Resolution:2.37 Å Release Date: 2022-10-05 Classification: VIRAL PROTEIN Ligands: IOD, 9WW, CL |
 |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:2.15 Å Release Date: 2022-09-28 Classification: VIRAL PROTEIN Ligands: IOD, CL |
 |
Disulfide Stabilized Hiv-1 Ca Hexamer In Complex With Capsid Inhibitor (S)-N-(1-(3-(4-Chloro-3-(Methylsulfonamido)-1-(2,2,2-Trifluoroethyl)-1H-Indazol-7-Yl)-6-(3-Methyl-3-(Methylsulfonyl)But-1-Yn-1-Yl)Pyridin-2-Yl)-2-(3,5-Difluorophenyl)Ethyl)-2-(3-(Trifluoromethyl)-4,5,6,7-Tetrahydro-1H-Indazol-1-Yl)Acetamide
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:2.27 Å Release Date: 2022-08-03 Classification: VIRAL PROTEIN Ligands: 61F, IOD, CL |
 |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.97 Å Release Date: 2022-08-03 Classification: VIRAL PROTEIN Ligands: IOD, CL |
 |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:2.16 Å Release Date: 2022-07-27 Classification: Viral Protein/Inhibitor Ligands: IOD, CL |
 |
Co-Crystal Structure Of Q67H Mutant Of Disulfide Stabilized Hiv-1 Ca Hexamer And Lenacapavir
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:2.46 Å Release Date: 2022-07-27 Classification: Viral Protein/Inhibitor Ligands: QNG, IOD, CL |
 |
Co-Crystal Structure Of Lenacapavir Bound To Q67H/N74D Mutant Of Disulfide Stabilized Hiv-1 Ca Hexamer
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:2.32 Å Release Date: 2022-07-27 Classification: Viral Protein/Inhibitor Ligands: QNG, CL, IOD |
 |
Co-Crystal Structure Of Lenacapavir Bound To N74D Mutant Of Disulfide Stabilized Hiv-1 Ca Hexamer
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:3.32 Å Release Date: 2022-07-27 Classification: Viral Protein/Inhibitor Ligands: QNG, CL, IOD |
 |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:2.22 Å Release Date: 2020-10-21 Classification: VIRAL PROTEIN Ligands: QNG, IOD, CL |
 |
Organism: Human immunodeficiency virus 1
Method: ELECTRON MICROSCOPY Release Date: 2020-10-21 Classification: VIRAL PROTEIN |
 |
Hiv-1 Integrase Catalytic Core Domain Complexed With Allosteric Inhibitor Bi-224436
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:2.10 Å Release Date: 2019-12-11 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: L3D |
 |
Hiv-1 Integrase Catalytic Core Domain Complexed With Allosteric Inhibitor (2S)-Tert-Butoxy[3-(3,4-Dihydro-2H-1-Benzopyran-6-Yl)-1-Phenylisoquinolin-4-Yl]Acetic Acid
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:2.20 Å Release Date: 2019-03-06 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: J3M |
 |
Hiv-1 Integrase Catalytic Core Domain Complexed With Allosteric Inhibitor (2S)-[1-(1-Benzyl-1H-Pyrazol-4-Yl)-3-(3,4-Dihydro-2H-1-Benzopyran-6-Yl)Isoquinolin-4-Yl](Tert-Butoxy)Acetic Acid
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:2.49 Å Release Date: 2019-03-06 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: J3P |